Article
The RAS mutation status predicts survival in patients undergoing hepatic resection for colorectal liver metastases: The results from a genetic analysis of all-RAS.
Journal of surgical oncology - 1 Mar 2018
Amikura Katsumi, Akagi Kiwamu, Ogura Toshiro, Takahashi Amane, Sakamoto Hirohiko
Abstract excerpt
INTRODUCTION: We investigated the impact of mutations in KRAS exons 3-4 and NRAS exons 2-3 in addition to KRAS exon 2, so-called all-RAS mutations, in patients with colorectal liver metastasis (CLM) undergoing hepatic resection. METHODS: We analyzed 421 samples from CLM patients for their all-RAS mutation status to compare the overall survival rate (OS), recurrence-free survival rate (RFS), and the pattern of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
